期刊
ANTICANCER RESEARCH
卷 39, 期 7, 页码 3395-3404出版社
INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.13483
关键词
Cancer drug resistance; extracellular vesicles; exosomes; ectosomes; microvesicles; sequential centrifugation; review
类别
资金
- Anelise-Asmussen-Stiftung, Luebeck [180802]
- LEO Pharma Germany [180208]
Although modern anticancer drugs have made great progress in disease treatment, the occurrence of drug resistance often leads to treatment failure. Understanding the molecular basis of resistance mechanisms is important to determine prognosis and develop strategies for circumvention. In this context, subcellular vesicles released by cancer cells have been identified to mediate cellular resistance by various mechanisms. Such extracellular vesicles (EVs) can be subdivided into exosomes and ectosomes based on their size, cargo, and mechanism of formation. The unveiling of EV-targeted treatment options depends on a sound knowledge on EV biology including biogenesis, release, targeting to recipient cells, and uptake. In this review, we focus on EVs as mediators of cancer drug resistance with a particular emphasis on the distinction of exosomes and ectosomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据